Parrish K, Gestal M
Infect Immun. 2024; 92(9):e0017524.
PMID: 39007622
PMC: 11385729.
DOI: 10.1128/iai.00175-24.
Liu S, Ezran C, Wang M, Li Z, Awayan K, Long J
Nat Commun. 2024; 15(1):2188.
PMID: 38467625
PMC: 10928088.
DOI: 10.1038/s41467-024-46070-9.
Bekdas M, Saygi B, Baranoglu Kilinc Y, Kilinc E
Eur J Pediatr. 2024; 183(4):1619-1627.
PMID: 38183438
PMC: 11001734.
DOI: 10.1007/s00431-023-05417-y.
First N, Pedreira-Lopez J, San-Silvestre M, Parrish K, Lu X, Gestal M
Front Cell Infect Microbiol. 2023; 13:1111502.
PMID: 37065208
PMC: 10090565.
DOI: 10.3389/fcimb.2023.1111502.
Kaczynska K, Zajac D, Wojciechowski P, Jampolska M
Int J Mol Sci. 2021; 22(24).
PMID: 34948451
PMC: 8707337.
DOI: 10.3390/ijms222413656.
VIP/PACAP signaling as an alternative target during hyperoxic exposure in preterm newborns.
Thaci Q, Recica S, Kryeziu I, Mitrokhin V, Kamkin A, Sopi R
Physiol Res. 2021; 70(4):489-499.
PMID: 34062074
PMC: 8820544.
DOI: 10.33549/physiolres.934638.
A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases.
Martinez C, Juarranz Y, Gutierrez-Canas I, Carrion M, Perez-Garcia S, Villanueva-Romero R
Int J Mol Sci. 2019; 21(1).
PMID: 31861827
PMC: 6982157.
DOI: 10.3390/ijms21010065.
Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.
Atanasova K, Reznikov L
Respir Res. 2018; 19(1):149.
PMID: 30081920
PMC: 6090699.
DOI: 10.1186/s12931-018-0846-4.
[Effects of vasoactive intestinal peptide on airway inflammation and Th17/Treg balance in asthmatic mice].
Ke L, Wang F, Luo Y
Zhongguo Dang Dai Er Ke Za Zhi. 2017; 19(6):699-704.
PMID: 28606240
PMC: 7390301.
Lung ischemia reperfusion injury: the therapeutic role of dipeptidyl peptidase 4 inhibition.
Beckers P, Gielis J, Van Schil P, Adriaensen D
Ann Transl Med. 2017; 5(6):129.
PMID: 28462209
PMC: 5395493.
DOI: 10.21037/atm.2017.01.41.
Glucocorticoid receptor expression on acute lung injury induced by endotoxin in rats.
Zhang Y, Zuo W, Rong Q, Teng G, Zhang Y
World J Emerg Med. 2014; 1(1):65-9.
PMID: 25214944
PMC: 4129762.
Expression of VPAC1 in a murine model of allergic asthma.
Lauenstein H, Quarcoo D, Welte T, Braun A, Groneberg D
J Occup Med Toxicol. 2013; 8(1):28.
PMID: 24107483
PMC: 3852716.
DOI: 10.1186/1745-6673-8-28.
Vasoactive intestinal Peptide inhaled agonists: potential role in respiratory therapeutics.
Mathioudakis A, Chatzimavridou-Grigoriadou V, Evangelopoulou E, Mathioudakis G
Hippokratia. 2013; 17(1):12-6.
PMID: 23935337
PMC: 3738270.
VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins.
Couvineau A, Laburthe M
Br J Pharmacol. 2011; 166(1):42-50.
PMID: 21951273
PMC: 3415636.
DOI: 10.1111/j.1476-5381.2011.01676.x.
Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.
Tan Y, Waschek J
ASN Neuro. 2011; 3(4).
PMID: 21895607
PMC: 3189630.
DOI: 10.1042/AN20110024.
Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.
Wu D, Lee D, Sung Y
Respir Res. 2011; 12:45.
PMID: 21477377
PMC: 3090995.
DOI: 10.1186/1465-9921-12-45.
Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptors.
Tannu S, Renzetti L, Tare N, Ventre J, Lavelle D, Lin T
Br J Pharmacol. 2010; 161(6):1329-42.
PMID: 20735404
PMC: 3000657.
DOI: 10.1111/j.1476-5381.2010.00975.x.
Vasoactive intestinal polypeptide relaxes isolated rat pulmonary artery rings through two distinct mechanisms.
Zhang S, Liu Y, Guo S, Zhang J, Chu X, Jiang C
J Physiol Sci. 2010; 60(6):389-97.
PMID: 20694540
PMC: 10717274.
DOI: 10.1007/s12576-010-0107-x.
Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS.
Sun C, Song D, Davis-Taber R, Barrett L, Scott V, Richardson P
Proc Natl Acad Sci U S A. 2007; 104(19):7875-80.
PMID: 17470806
PMC: 1876540.
DOI: 10.1073/pnas.0611397104.
Models of chronic obstructive pulmonary disease.
Groneberg D, Chung K
Respir Res. 2004; 5:18.
PMID: 15522115
PMC: 533858.
DOI: 10.1186/1465-9921-5-18.